# A Research Study for Patients With Metastatic Renal Cell Carcinoma

> **NCT00106613** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 30 (actual)

## Conditions studied

- Carcinoma, Renal Cell
- Neoplasm Metastasis

## Interventions

- **DRUG:** FK228 (romidepsin)

## Key facts

- **NCT ID:** NCT00106613
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05-01
- **Primary completion:** 2004-08-01
- **Final completion:** 2004-08-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106613, "A Research Study for Patients With Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00106613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*